Atara Bio relies on ArganoArbela as an extension of their IT team
As a leading off-the-shelf, allogenic T-cell immunotherapy manufacturer that develops treatments for patients with cancer, autoimmune, and viral diseases, Atara Bio requires technology that is timely and accurate to help deliver the right treatment to patients in need as quickly as possible.